FORM N-PX
ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT INVESTMENT COMPANY
INVESTMENT COMPANY ACT FILE NUMBER: 811-03010
EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER: Fidelity Advisor Series VII
Fund Name: Fidelity Advisor Biotechnology Fund
82 DEVONSHIRE STREET, BOSTON, MA 02109
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)
SCOTT C.GOEBEL, SECRETARY, 82 DEVONSHIRE STREET, BOSTON, MA 02109
(NAME AND ADDRESS OF AGENT FOR SERVICE)
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: 617-563-7000
DATE OF FISCAL YEAR END: JULY 31
DATE OF REPORTING PERIOD: 06/30/2008
SIGNATURES
PURSUANT TO THE REQUIREMENTS OF THE INVESTMENT COMPANY ACT OF 1940, THE REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE UNDERSIGNED, THERE UNTO DULY AUTHORIZED.
Fidelity Advisor Series VII
BY: /s/ KENNETH B. ROBINS*
KENNETH B. ROBINS, TREASURER
DATE: 08/12/2008 01:25:17 PM
*BY: /s/ CLAIRE S. WALPOLE
CLAIRE S. WALPOLE, VICE PRESIDENT, FIDELITY MANAGEMENT & RESEARCH COMPANY, PURSUANT TO A POWER OF ATTORNEY DATED JUNE 11, 2008 AND FILED HEREWITH.
VOTE SUMMARY REPORT
Fidelity Advisor Biotechnology Fund
07/01/2007- 06/30/2008
Note: The Security ID will be the CUSIP (Committee on Uniform Securities Identification Procedures) when available. When CUSIP is not available, an alternate identifier, e.g., CINS, will be provided.
| ISSUER NAME: 3S BIO INC MEETING DATE: 10/17/2007 | ||||
| TICKER: SSRX SECURITY ID: 88575Y105 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | TO ADOPT THE COMPANY S ANNUAL REPORT ON FORM 20-F FOR THE FISCAL YEAR ENDED DECEMBER 31, 2006. | Management | For | For |
| 2 | TO ADOPT THE COMPANY S CONSOLIDATED FINANCIAL STATEMENTS FOR THE FISCAL YEAR ENDED DECEMBER 31, 2006 AND REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. | Management | For | For |
| 3 | TO RE-ELECT LIPING XU, BIN HUANG, LAWRENCE S. WIZEL, GUANJIN HU AND MOUJIA QI AS DIRECTORS OF THE COMPANY WHO WILL RETIRE AND BE ELIGIBLE FOR RE-ELECTION AT THE MEETING. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ACADIA PHARMACEUTICALS INC. MEETING DATE: 06/13/2008 | ||||
| TICKER: ACAD SECURITY ID: 004225108 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT MICHAEL BORER AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT MARY ANN GRAY AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT LESTER J. KAPLAN AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF OUR BOARD OF DIRECTORS OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ACORDA THERAPEUTICS, INC. MEETING DATE: 05/21/2008 | ||||
| TICKER: ACOR SECURITY ID: 00484M106 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT RON COHEN, M.D. AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT LORIN J. RANDALL AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT STEVEN M. RAUSCHER AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE APPOINTMENT OF KPMG LLP AS THE COMPANY S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| 3 | TO TRANSACT SUCH OTHER BUSINESS AS MAY PROPERLY COME BEFORE THE MEETING OR ANY ADJOURNMENT THEREOF. | Management | For | Against |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: AFFYMAX, INC. MEETING DATE: 05/22/2008 | ||||
| TICKER: AFFY SECURITY ID: 00826A109 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT R. LEE DOUGLAS AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT N. GALAKATOS, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT JOHN P. WALKER AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF AFFYMAX FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: AKORN, INC. MEETING DATE: 05/22/2008 | ||||
| TICKER: AKRX SECURITY ID: 009728106 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT JOHN N. KAPOOR, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT ARTHUR S. PRZYBYL AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT JERRY N. ELLIS AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT RONALD M. JOHNSON AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT JERRY I. TREPPEL AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT SUBHASH KAPRE, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT RANDALL J. WALL AS A DIRECTOR | Management | For | For |
| 2 | PROPOSAL TO RATIFY THE SELECTION OF ERNST & YOUNG LLP TO SERVE AS AKORN S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ALEXION PHARMACEUTICALS, INC. MEETING DATE: 05/09/2008 | ||||
| TICKER: ALXN SECURITY ID: 015351109 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT LEONARD BELL AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT DAVID W. KEISER AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT MAX LINK AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT JOSEPH A. MADRI AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT LARRY L. MATHIS AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT R. DOUGLAS NORBY AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT ALVIN S. PARVEN AS A DIRECTOR | Management | For | For |
| 1. 8 | ELECT RUEDI E. WAEGER AS A DIRECTOR | Management | For | For |
| 2 | APPROVAL OF THE AMENDMENT TO 2004 INCENTIVE PLAN, AS DESCRIBED IN THE ACCOMPANYING PROXY STATEMENT, INCLUDING TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AVAILABLE FOR ISSUANCE BY 2.4 MILLION SHARES (SUBJECT TO ADJUSTMENT IN THE EVENT OF STOCK SPLITS AND OTHER SIMILAR EVENTS). | Management | For | For |
| 3 | RATIFICATION OF APPOINTMENT BY THE BOARD OF DIRECTORS OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ALKERMES, INC. MEETING DATE: 10/09/2007 | ||||
| TICKER: ALKS SECURITY ID: 01642T108 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT FLOYD E. BLOOM AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT ROBERT A. BREYER AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT GERALDINE HENWOOD AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT PAUL J. MITCHELL AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT RICHARD F. POPS AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT ALEXANDER RICH AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT DAVID A. BROECKER AS A DIRECTOR | Management | For | For |
| 1. 8 | ELECT MARK B. SKALETSKY AS A DIRECTOR | Management | For | For |
| 1. 9 | ELECT MICHAEL A. WALL AS A DIRECTOR | Management | For | For |
| 2 | TO APPROVE AN AMENDED AND RESTATED 1999 STOCK OPTION PLAN. | Management | For | For |
| 3 | TO APPROVE AN AMENDMENT TO THE 2002 RESTRICTED STOCK AWARD PLAN TO INCREASE THE NUMBER OF SHARES AUTHORIZED FOR ISSUANCE THEREUNDER, BY 700,000 SHARES. | Management | For | For |
| 4 | TO APPROVE AN AMENDMENT TO THE 2006 STOCK OPTION PLAN FOR NON-EMPLOYEE DIRECTORS TO INCREASE THE NUMBER OF SHARES ISSUABLE UPON EXERCISE OF OPTIONS GRANTED THEREUNDER, BY 240,000 SHARES. | Management | For | For |
| 5 | TO RATIFY PRICEWATERHOUSECOOPERS LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR FISCAL YEAR 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ALNYLAM PHARMACEUTICALS, INC. MEETING DATE: 06/03/2008 | ||||
| TICKER: ALNY SECURITY ID: 02043Q107 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT J.M. MARAGANORE, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT PAUL R. SCHIMMEL, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT PHILLIP A. SHARP, PH.D. AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP, AN INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, AS ALNYLAM S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: AMAG PHARMACEUTICALS, INC. MEETING DATE: 11/27/2007 | ||||
| TICKER: AMAG SECURITY ID: 00163U106 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | PROPOSAL TO APPROVE THE 2007 EQUITY INCENTIVE PLAN | Management | For | Against |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: AMAG PHARMACEUTICALS, INC. MEETING DATE: 05/06/2008 | ||||
| TICKER: AMAG SECURITY ID: 00163U106 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT JOSEPH V. BONVENTRE AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT MICHAEL D. LOBERG AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT MICHAEL NARACHI AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT BRIAN J.G. PEREIRA AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT DAVEY S. SCOON AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT MARK SKALETSKY AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT RON ZWANZIGER AS A DIRECTOR | Management | For | For |
| 2 | PROPOSAL TO APPROVE AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION, AS AMENDED, INCREASING THE NUMBER OF SHARES OF OUR COMMON STOCK AUTHORIZED THEREUNDER FROM 25,000,000 TO 58,750,000. | Management | For | For |
| 3 | PROPOSAL TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT AUDITOR FOR THE YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: AMGEN INC. MEETING DATE: 05/07/2008 | ||||
| TICKER: AMGN SECURITY ID: 031162100 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | ELECTION OF DIRECTOR: DR. DAVID BALTIMORE | Management | For | For |
| 2 | ELECTION OF DIRECTOR: MR. FRANK J. BIONDI, JR. | Management | For | For |
| 3 | ELECTION OF DIRECTOR: MR. JERRY D. CHOATE | Management | For | For |
| 4 | ELECTION OF DIRECTOR: DR. VANCE D. COFFMAN | Management | For | For |
| 5 | ELECTION OF DIRECTOR: MR. FREDERICK W. GLUCK | Management | For | For |
| 6 | ELECTION OF DIRECTOR: MR. FRANK C. HERRINGER | Management | For | For |
| 7 | ELECTION OF DIRECTOR: DR. GILBERT S. OMENN | Management | For | For |
| 8 | ELECTION OF DIRECTOR: MS. JUDITH C. PELHAM | Management | For | For |
| 9 | ELECTION OF DIRECTOR: ADM. J. PAUL REASON, USN (RETIRED) | Management | For | For |
| 10 | ELECTION OF DIRECTOR: MR. LEONARD D. SCHAEFFER | Management | For | For |
| 11 | ELECTION OF DIRECTOR: MR. KEVIN W. SHARER | Management | For | For |
| 12 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR THE FISCAL YEAR | Management | For | For |
| 13 | STOCKHOLDER PROPOSAL #1 (SIMPLE MAJORITY VOTE) | Shareholder | Against | For |
| 14 | STOCKHOLDER PROPOSAL #2 (ANIMAL WELFARE) | Shareholder | Against | Abstain |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: AMYLIN PHARMACEUTICALS, INC. MEETING DATE: 05/30/2008 | ||||
| TICKER: AMLN SECURITY ID: 032346108 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT ADRIAN ADAMS AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT STEVEN R. ALTMAN AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT TERESA BECK AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT DANIEL M. BRADBURY AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT JOSEPH C. COOK, JR. AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT KARIN EASTHAM AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT JAMES R. GAVIN III AS A DIRECTOR | Management | For | For |
| 1. 8 | ELECT GINGER L. GRAHAM AS A DIRECTOR | Management | For | For |
| 1. 9 | ELECT HOWARD E. GREENE, JR. AS A DIRECTOR | Management | For | For |
| 1. 10 | ELECT JAY S. SKYLER AS A DIRECTOR | Management | For | For |
| 1. 11 | ELECT JOSEPH P. SULLIVAN AS A DIRECTOR | Management | For | For |
| 1. 12 | ELECT JAMES N. WILSON AS A DIRECTOR | Management | For | For |
| 2 | TO APPROVE AN INCREASE OF 3,500,000 SHARES IN THE AGGREGATE NUMBER OF SHARES OF THE COMPANY S COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE COMPANY S 2001 EQUITY INCENTIVE PLAN. | Management | For | Against |
| 3 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY OR ITS FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: APPLERA CORPORATION MEETING DATE: 10/18/2007 | ||||
| TICKER: CRA �� SECURITY ID: 038020202 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT RICHARD H. AYERS AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT JEAN-LUC BELINGARD AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT ROBERT H. HAYES AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT ARNOLD J. LEVINE AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT WILLIAM H. LONGFIELD AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT ELAINE R. MARDIS AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT THEODORE E. MARTIN AS A DIRECTOR | Management | For | For |
| 1. 8 | ELECT CAROLYN W. SLAYMAN AS A DIRECTOR | Management | For | For |
| 1. 9 | ELECT JAMES R. TOBIN AS A DIRECTOR | Management | For | For |
| 1. 10 | ELECT TONY L. WHITE AS A DIRECTOR | Management | For | For |
| 2 | RATIFICATION OF THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING JUNE 30, 2008. | Management | For | For |
| 3 | APPROVAL OF AN EXTENSION OF THE TERM OF THE APPLERA CORPORATION 1999 EMPLOYEE STOCK PURCHASE PLAN. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ARENA PHARMACEUTICALS, INC. MEETING DATE: 06/11/2008 | ||||
| TICKER: ARNA SECURITY ID: 040047102 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT JACK LIEF AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT DOMINIC P. BEHAN, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT DONALD D. BELCHER AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT SCOTT H. BICE AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT H.F. HIXSON, JR., PH.D. AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT J.C. LA FORCE, JR., PHD AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT TINA NOVA BENNETT, PH.D AS A DIRECTOR | Management | For | For |
| 1. 8 | ELECT PHILLIP M. SCHNEIDER AS A DIRECTOR | Management | For | For |
| 1. 9 | ELECT CHRISTINE A. WHITE, M.D AS A DIRECTOR | Management | For | For |
| 1. 10 | ELECT RANDALL E. WOODS AS A DIRECTOR | Management | For | For |
| 2 | RATIFICATION OF APPOINTMENT OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ARRAY BIOPHARMA INC. MEETING DATE: 11/01/2007 | ||||
| TICKER: ARRY SECURITY ID: 04269X105 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT DAVID L. SNITMAN, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT GIL J. VAN LUNSEN AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT J.L. ZABRISKIE, PH.D. AS A DIRECTOR | Management | For | For |
| 2 | APPROVAL OF AN AMENDMENT TO THE ARRAY BIOPHARMA INC. AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 60,000,000 TO 120,000,000. | Management | For | For |
| 3 | RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR THE FISCAL YEAR ENDING JUNE 30, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: AUXILIUM PHARMACEUTICALS, INC. MEETING DATE: 06/12/2008 | ||||
| TICKER: AUXL SECURITY ID: 05334D107 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT ROLF A. CLASSON AS A DIRECTOR | Management | For | Withhold |
| 1. 2 | ELECT AL ALTOMARI AS A DIRECTOR | Management | For | Withhold |
| 1. 3 | ELECT ARMANDO ANIDO AS A DIRECTOR | Management | For | Withhold |
| 1. 4 | ELECT EDWIN A. BESCHERER, JR. AS A DIRECTOR | Management | For | Withhold |
| 1. 5 | ELECT P.O. CHAMBON, M.D., PHD AS A DIRECTOR | Management | For | Withhold |
| 1. 6 | ELECT OLIVER S. FETZER, PH.D. AS A DIRECTOR | Management | For | Withhold |
| 1. 7 | ELECT RENATO FUCHS, PH.D. AS A DIRECTOR | Management | For | Withhold |
| 1. 8 | ELECT DENNIS LANGER, M.D. J.D AS A DIRECTOR | Management | For | Withhold |
| 1. 9 | ELECT DENNIS J. PURCELL AS A DIRECTOR | Management | For | Withhold |
| 2 | TO RATIFY THE SELECTION BY THE AUDIT AND COMPLIANCE COMMITTEE OF THE COMPANY S BOARD OF DIRECTORS OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: BIODEL, INC. MEETING DATE: 02/28/2008 | ||||
| TICKER: BIOD SECURITY ID: 09064M105 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT ALBERT CHA AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT DAVID KROIN AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT SAMUEL WERTHEIMER AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE APPOINTMENT OF BDO SEIDMAN, LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING SEPTEMBER 30, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: BIOGEN IDEC INC. MEETING DATE: 06/19/2008 | ||||
| TICKER: BIIB SECURITY ID: 09062X103 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT STELIOS PAPADOPOULOS AS A DIRECTOR | Management | For | None |
| 1. 2 | ELECT CECIL PICKETT AS A DIRECTOR | Management | For | None |
| 1. 3 | ELECT LYNN SCHENK AS A DIRECTOR | Management | For | None |
| 1. 4 | ELECT PHILLIP SHARP AS A DIRECTOR | Management | For | None |
| 2 | TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | None |
| 3 | TO APPROVE OUR 2008 OMNIBUS EQUITY PLAN. | Management | For | None |
| 4 | TO APPROVE OUR 2008 PERFORMANCE-BASED MANAGEMENT INCENTIVE PLAN. | Management | For | None |
| 5 | SHAREHOLDER PROPOSAL TO AMEND THE COMPANY S BYLAWS. | Shareholder | Against | None |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: BIOGEN IDEC INC. MEETING DATE: 06/19/2008 | ||||
| TICKER: BIIB SECURITY ID: 09062X103 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT DR. A. J. DENNER AS A DIRECTOR | Shareholder | Unknown | For |
| 1. 2 | ELECT DR. ANNE B. YOUNG AS A DIRECTOR | Shareholder | Unknown | For |
| 1. 3 | ELECT PROF. R. C. MULLIGAN AS A DIRECTOR | Shareholder | Unknown | For |
| 1. 4 | ELECT MGT NOM- PHILLIP SHARP AS A DIRECTOR | Shareholder | Unknown | For |
| 2 | APPROVAL OF THE BYLAW AMENDMENTS. | Shareholder | Unknown | For |
| 3 | RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. | Shareholder | Unknown | For |
| 4 | APPROVAL OF 2008 OMNIBUS EQUITY PLAN. | Shareholder | Unknown | Against |
| 5 | APROVAL OF 2008 PERFORMANCE-BASED MANAGEMENT INCENTIVE PLAN. | Shareholder | Unknown | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: BIOMARIN PHARMACEUTICAL INC. MEETING DATE: 05/22/2008 | ||||
| TICKER: BMRN SECURITY ID: 09061G101 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT JEAN-JACQUES BIENAIME AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT MICHAEL GREY AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT ELAINE J. HERON AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT JOSEPH KLEIN, III AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT PIERRE LAPALME AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT V. BRYAN LAWLIS AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT ALAN LEWIS AS A DIRECTOR | Management | For | For |
| 1. 8 | ELECT RICHARD A. MEIER AS A DIRECTOR | Management | For | For |
| 2 | PROPOSAL TO RATIFY THE SELECTION BY THE BOARD OF DIRECTORS OF KPMG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: CARDIOME PHARMA CORP. MEETING DATE: 09/05/2007 | ||||
| TICKER: CRME SECURITY ID: 14159U202 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | TO PASS THE ORDINARY RESOLUTION, THE FULL TEXT OF WHICH IS SET OUT IN THE INFORMATION CIRCULAR, TO RATIFY, CONFIRM AND APPROVE CERTAIN AMENDMENTS AND RELATED RESOLUTIONS RESPECTING THE CORPORATION S 2001 INCENTIVE STOCK OPTION PLAN. | Management | For | Against |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: CATALYST PHARMACEUTICAL PARTNERS, IN MEETING DATE: 08/08/2007 | ||||
| TICKER: CPRX SECURITY ID: 14888U101 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT PATRICK J. MCENANY AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT PHILIP H. COELHO AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT HUBERT E. HUCKEL, M.D. AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT CHARLES B. O'KEEFFE AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT DAVID S. TIERNEY, M.D. AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT MILTON J. WALLACE AS A DIRECTOR | Management | For | For |
| 2 | TO TRANSACT SUCH OTHER BUSINESS AS MAY PROPERLY COME BEFORE THE MEETING | Management | For | Abstain |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. MEETING DATE: 06/18/2008 | ||||
| TICKER: CPRX SECURITY ID: 14888U101 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT PATRICK J. MCENANY AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT PHILIP H. COELHO AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT HUBERT E. HUCKEL, M.D. AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT CHARLES B. O'KEEFFE AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT DAVID S. TIERNEY, M.D. AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT MILTON J. WALLACE AS A DIRECTOR | Management | For | For |
| 2 | TO TRANSACT SUCH OTHER BUSINESS AS MAY PROPERLY COME BEFORE THE MEETING. | Management | For | Against |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: CELGENE CORPORATION MEETING DATE: 06/18/2008 | ||||
| TICKER: CELG SECURITY ID: 151020104 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT SOL J. BARER, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT ROBERT J. HUGIN AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT MICHAEL D. CASEY AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT RODMAN L. DRAKE AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT A. HULL HAYES, JR., MD AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT GILLA KAPLAN, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT JAMES J. LOUGHLIN AS A DIRECTOR | Management | For | For |
| 1. 8 | ELECT ERNEST MARIO, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 9 | ELECT WALTER L. ROBB, PH.D. AS A DIRECTOR | Management | For | For |
| 2 | RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| 3 | APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE COMPANY S 1998 STOCK INCENTIVE PLAN (TO BE RENAMED THE 2008 STOCK INCENTIVE PLAN). | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: CEPHALON, INC. MEETING DATE: 05/22/2008 | ||||
| TICKER: CEPH SECURITY ID: 156708109 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT FRANK BALDINO, JR., PHD AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT WILLIAM P. EGAN AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT MARTYN D. GREENACRE AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT VAUGHN M. KAILIAN AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT KEVIN E. MOLEY AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT CHARLES A. SANDERS, M.D AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT GAIL R. WILENSKY, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 8 | ELECT DENNIS L. WINGER AS A DIRECTOR | Management | For | For |
| 2 | APPROVAL OF AMENDMENTS TO THE 2004 EQUITY COMPENSATION PLAN INCREASING THE NUMBER OF SHARES AUTHORIZED FOR ISSUANCE AND ESTABLISHING PERFORMANCE GOALS SO THAT STOCK AWARD GRANTED UNDER THE PLAN MAY QUALIFY AS QUALIFIED PERFORMANCE-BASED COMPENSATION | Management | For | Against |
| 3 | RATIFICATION OF APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR THE YEAR ENDING DECEMBER 31, 2008 | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: CEPHEID MEETING DATE: 04/24/2008 | ||||
| TICKER: CPHD SECURITY ID: 15670R107 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT ROBERT J. EASTON AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT MITCHELL D. MROZ AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT HOLLINGS C. RENTON AS A DIRECTOR | Management | For | For |
| 2 | TO AMEND AND RESTATE CEPHEID S 2006 EQUITY INCENTIVE PLAN. | Management | For | Against |
| 3 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF CEPHEID FOR THE FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: CLINICAL DATA, INC. MEETING DATE: 09/25/2007 | ||||
| TICKER: CLDA SECURITY ID: 18725U109 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT RANDAL J. KIRK AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT ANDREW J. FROMKIN AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT LARRY D. HORNER AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT ARTHUR B. MALMAN AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT BURTON E. SOBEL, M.D. AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT RICHARD J. WALLACE AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE APPOINTMENT OF DELOITTE & TOUCHE, LLP AS CLINICAL DATA S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE 2008 FISCAL YEAR. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: COUGAR BIOTECHNOLOGY, INC. MEETING DATE: 06/17/2008 | ||||
| TICKER: CGRB SECURITY ID: 222083107 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT ARIE S. BELLDEGRUN AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT ALAN H. AUERBACH AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT HAROLD J. MEYERS AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT MICHAEL S. RICHMAN AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT RUSSELL H. ELLISON AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT THOMAS R. MALLEY AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT SAMUEL R. SAKS AS A DIRECTOR | Management | For | For |
| 2 | PROPOSAL TO RATIFY THE APPOINTMENT OF J.H. COHN LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2008 | Management | For | For |
| 3 | PROPOSAL TO RATIFY AND APPROVE AN AMENDMENT TO THE COMPANY S 2003 STOCK OPTION PLAN, AS DESCRIBED IN THE ACCOMPANYING PROXY STATEMENT | Management | For | Against |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: CUBIST PHARMACEUTICALS, INC. MEETING DATE: 06/11/2008 | ||||
| TICKER: CBST SECURITY ID: 229678107 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT MARTIN ROSENBERG AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT J. MATTHEW SINGLETON AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT MICHAEL B. WOOD AS A DIRECTOR | Management | For | For |
| 2 | A PROPOSAL TO AMEND OUR AMENDED AND RESTATED 2000 EQUITY INCENTIVE PLAN, OR EIP, TO INCREASE THE NUMBER OF SHARES ISSUABLE UNDER THE EIP BY 2,000,000 SHARES. | Management | For | Against |
| 3 | A PROPOSAL TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: DENDREON CORPORATION MEETING DATE: 06/04/2008 | ||||
| TICKER: DNDN SECURITY ID: 24823Q107 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT RICHARD B. BREWER AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT MITCHELL H. GOLD, M.D. AS A DIRECTOR | Management | For | For |
| 2 | APPROVAL OF THE RATIFICATION OF THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE CURRENT YEAR. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ELAN CORPORATION, PLC MEETING DATE: 05/22/2008 | ||||
| TICKER: ELN SECURITY ID: 284131208 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | TO RECEIVE AND CONSIDER THE FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2007. | Management | For | For |
| 2 | TO RE-ELECT MS. ANN MAYNARD GRAY WHO RETIRES FROM THE BOARD BY ROTATION IN ACCORDANCE WITH THE ARTICLES OF ASSOCIATION. | Management | For | For |
| 3 | TO RE-ELECT MR. KIERAN MCGOWAN WHO RETIRES FROM THE BOARD BY ROTATION IN ACCORDANCE WITH THE ARTICLES OF ASSOCIATION. | Management | For | For |
| 4 | TO RE-ELECT MR. KYRAN MCLAUGHLIN WHO RETIRES FROM THE BOARD IN ACCORDANCE WITH THE COMBINED CODE. | Management | For | For |
| 5 | TO RE-ELECT DR. DENNIS SELKOE WHO RETIRES FROM THE BOARD IN ACCORDANCE WITH THE COMBINED CODE. | Management | For | For |
| 6 | TO ELECT DR. FLOYD BLOOM WHO RETIRES FROM THE BOARD IN ACCORDANCE WITH THE ARTICLES OF ASSOCIATION. | Management | For | For |
| 7 | TO ELECT MR. JONAS FRICK WHO RETIRES FROM THE BOARD IN ACCORDANCE WITH THE ARTICLES OF ASSOCIATION. | Management | For | For |
| 8 | TO ELECT MR. GILES KERR WHO RETIRES FROM THE BOARD IN ACCORDANCE WITH THE ARTICLES OF ASSOCIATION. | Management | For | For |
| 9 | TO ELECT MR. JEFFREY SHAMES WHO RETIRES FROM THE BOARD IN ACCORDANCE WITH THE ARTICLES OF ASSOCIATION. | Management | For | For |
| 10 | TO AUTHORISE THE DIRECTORS TO FIX THE REMUNERATION OF THE AUDITORS. | Management | For | For |
| 11 | TO AUTHORISE THE DIRECTORS TO ISSUE SECURITIES. | Management | For | For |
| 12 | TO APPROVE THE 2006 LONG TERM INCENTIVE PLAN. | Management | For | Against |
| 13 | TO AUTHORISE THE DISAPPLICATION OF PRE-EMPTION RIGHTS ON THE ALLOTMENT OF UP TO 40 MILLION SHARES. | Management | For | For |
| 14 | TO AUTHORISE THE COMPANY TO MAKE MARKET PURCHASES OF ITS OWN SHARES. | Management | For | For |
| 15 | TO SET THE RE-ISSUE PRICE RANGE FOR TREASURY SHARES. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ENZON PHARMACEUTICALS, INC. MEETING DATE: 05/22/2008 | ||||
| TICKER: ENZN SECURITY ID: 293904108 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT ROLF A. CLASSON AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT ROBERT LEBUHN AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT ROBERT C. SALISBURY AS A DIRECTOR | Management | For | For |
| 2 | RATIFICATION OF THE SELECTION OF KPMG LLP TO AUDIT THE CONSOLIDATED FINANCIAL STATEMENTS OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: EXELIXIS, INC. MEETING DATE: 05/01/2008 | ||||
| TICKER: EXEL SECURITY ID: 30161Q104 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT S. PAPADOPOULOS, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT G.A. SCANGOS, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT FRANK MCCORMICK, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT LANCE WILLSEY, M.D. AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS EXELIXIS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING JANUARY 2, 2009. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: GENENTECH, INC. MEETING DATE: 04/15/2008 | ||||
| TICKER: DNA SECURITY ID: 368710406 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT HERBERT W. BOYER AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT WILLIAM M. BURNS AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT ERICH HUNZIKER AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT JONATHAN K.C. KNOWLES AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT ARTHUR D. LEVINSON AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT DEBRA L. REED AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT CHARLES A. SANDERS AS A DIRECTOR | Management | For | For |
| 2 | TO APPROVE AN AMENDMENT TO THE GENENTECH, INC. 1991 EMPLOYEE STOCK PLAN TO AUTHORIZE THE SALE OF AN ADDITIONAL 10,000,000 SHARES. | Management | For | For |
| 3 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF GENENTECH FOR THE YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: GENZYME CORPORATION MEETING DATE: 05/22/2008 | ||||
| TICKER: GENZ SECURITY ID: 372917104 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | THE RE-ELECTION OF DIRECTOR: DOUGLAS A. BERTHIAUME | Management | For | For |
| 2 | THE RE-ELECTION OF DIRECTOR: GAIL K. BOUDREAUX | Management | For | For |
| 3 | THE RE-ELECTION OF DIRECTOR: ROBERT J. CARPENTER | Management | For | For |
| 4 | THE RE-ELECTION OF DIRECTOR: CHARLES L. COONEY | Management | For | For |
| 5 | THE RE-ELECTION OF DIRECTOR: RICHARD F. SYRON | Management | For | Against |
| 6 | A PROPOSAL TO AMEND THE 2004 EQUITY INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK COVERED BY THE PLAN BY 2,250,000 SHARES. | Management | For | Against |
| 7 | A PROPOSAL TO AMEND THE 2007 DIRECTOR EQUITY PLAN TO SPECIFY THE AUTOMATIC GRANT PROVISIONS UNDER THE PLAN. | Management | For | For |
| 8 | A PROPOSAL TO RATIFY THE AUDIT COMMITTEE S SELECTION OF INDEPENDENT AUDITORS FOR 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: GILEAD SCIENCES, INC. MEETING DATE: 05/08/2008 | ||||
| TICKER: GILD SECURITY ID: 375558103 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT PAUL BERG AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT JOHN F. COGAN AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT ETIENNE F. DAVIGNON AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT JAMES M. DENNY AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT CARLA A. HILLS AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT JOHN W. MADIGAN AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT JOHN C. MARTIN AS A DIRECTOR | Management | For | For |
| 1. 8 | ELECT GORDON E. MOORE AS A DIRECTOR | Management | For | For |
| 1. 9 | ELECT NICHOLAS G. MOORE AS A DIRECTOR | Management | For | For |
| 1. 10 | ELECT GAYLE E. WILSON AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF GILEAD FOR THE FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| 3 | TO APPROVE THE PROPOSED AMENDMENT TO GILEAD S 2004 EQUITY INCENTIVE PLAN. | Management | For | For |
| 4 | TO APPROVE AN AMENDMENT TO GILEAD S RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE AUTHORIZED NUMBER OF SHARES OF GILEAD S COMMON STOCK FROM 1,400,000,000 TO 2,800,000,000 SHARES. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: GTX, INC. MEETING DATE: 04/30/2008 | ||||
| TICKER: GTXI SECURITY ID: 40052B108 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT ROBERT W KARR MD AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT ROSEMARY MAZANET MD PHD AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS GTX S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| 3 | TO APPROVE THE GTX, INC. 2004 EQUITY INCENTIVE PLAN, AS AMENDED. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: HALOZYME THERAPEUTICS, INC. MEETING DATE: 11/14/2007 | ||||
| TICKER: HALO SECURITY ID: 40637H109 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | TO APPROVE AN AGREEMENT AND PLAN OF MERGER PURSUANT TO WHICH WE WILL REINCORPORATE FROM THE STATE OF NEVADA TO THE STATE OF DELAWARE. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: HALOZYME THERAPEUTICS, INC. MEETING DATE: 05/08/2008 | ||||
| TICKER: HALO SECURITY ID: 40637H109 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT KATHRYN E. FALBERG AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT KENNETH J. KELLEY AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT JONATHAN E. LIM AS A DIRECTOR | Management | For | For |
| 2 | TO APPROVE OUR 2008 OUTSIDE DIRECTORS STOCK PLAN AND TO RESERVE AN AGGREGATE OF 600,000 SHARES OF OUR COMMON STOCK FOR ISSUANCE UNDER THE 2008 OUTSIDE DIRECTORS STOCK PLAN. | Management | For | For |
| 3 | TO APPROVE OUR 2008 STOCK PLAN AND TO RESERVE AN AGGREGATE OF 5,000,000 SHARES OF OUR COMMON STOCK FOR ISSUANCE UNDER THE 2008 STOCK PLAN. | Management | For | Against |
| 4 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: HUMAN GENOME SCIENCES, INC. MEETING DATE: 05/07/2008 | ||||
| TICKER: HGSI SECURITY ID: 444903108 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT TUAN HA-NGOC AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT ROBERT C. YOUNG, M.D. AS A DIRECTOR | Management | For | For |
| 2 | TO APPROVE AN AMENDMENT TO THE COMPANY S CERTIFICATE OF INCORPORATION TO DECLASSIFY THE BOARD OF DIRECTORS SO THAT DIRECTORS WILL BE ELECTED ANNUALLY. | Management | For | For |
| 3 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: INCYTE CORPORATION MEETING DATE: 05/22/2008 | ||||
| TICKER: INCY SECURITY ID: 45337C102 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT RICHARD U. DE SCHUTTER AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT BARRY M. ARIKO AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT JULIAN C. BAKER AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT PAUL A. BROOKE AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT MATTHEW W. EMMENS AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT PAUL A. FRIEDMAN AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT JOHN F. NIBLACK AS A DIRECTOR | Management | For | For |
| 1. 8 | ELECT ROY A. WHITFIELD AS A DIRECTOR | Management | For | For |
| 2 | TO AMEND THE COMPANY S 1991 STOCK PLAN TO INCREASE THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE THEREUNDER BY 4,000,000 SHARES, FROM 25,350,000 SHARES TO 29,350,000 SHARES. | Management | For | Against |
| 3 | TO AMEND THE COMPANY S 1997 EMPLOYEE STOCK PURCHASE PLAN TO INCREASE THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE THEREUNDER BY 750,000 SHARES FROM 3,850,000 SHARES TO 4,600,000 SHARES. | Management | For | For |
| 4 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: INDEVUS PHARMACEUTICALS, INC. MEETING DATE: 03/11/2008 | ||||
| TICKER: IDEV SECURITY ID: 454072109 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT GLENN L. COOPER, M.D. AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT ANDREW FERRARA AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT JAMES C. GALE AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT MICHAEL E. HANSON AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT STEPHEN C. MCCLUSKI AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT CHERYL P. MORLEY AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT MALCOLM MORVILLE, PH.D. AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS INDEVUS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ISIS PHARMACEUTICALS, INC. MEETING DATE: 06/05/2008 | ||||
| TICKER: ISIS SECURITY ID: 464330109 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT SPENCER R. BERTHELSEN AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT B. LYNNE PARSHALL AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT JOSEPH H. WENDER AS A DIRECTOR | Management | For | For |
| 2 | TO APPROVED AN AMENDMENT TO THE 2002 NON-EMPLOYEE DIRECTORS STOCK OPTION PLAN TO INCREASE THE ANNUAL NONDISCRETIONARY STOCK OPTION GRANT FOR OUR NON-EMPLOYEE DIRECTORS FROM 12,500 SHARES TO 15,000 SHARES AND THE INITIAL STOCK OPTION GRANT FROM 20,000 SHARES TO 30,000 SHARES. | Management | For | For |
| 3 | TO APPROVE AN INCREASE IN SHARES RESERVED FOR ISSUANCE UNDER THE 1989 STOCK OPTION PLAN FROM 13,200,000 SHARES TO 16,700,000 SHARES. | Management | For | For |
| 4 | TO RATIFY THE AUDIT COMMITTEE S SELECTION OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS FOR OUR 2008 FISCAL YEAR. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: JAZZ PHARMACEUTICALS INC MEETING DATE: 06/03/2008 | ||||
| TICKER: JAZZ SECURITY ID: 472147107 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT BRYAN C. CRESSEY AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT JAIMIN R. PATEL AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT JAMES B. TANANBAUM, M.D AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT NATHANIEL M. ZILKHA AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS JAZZ PHARMACEUTICALS, INC. S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: LIGAND PHARMACEUTICALS INCORPORATED MEETING DATE: 05/29/2008 | ||||
| TICKER: LGND SECURITY ID: 53220K207 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT JASON ARYEH AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT TODD C. DAVIS AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT ELIZABETH M. GREETHAM AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT JOHN L. HIGGINS AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT DAVID M. KNOTT AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT JOHN W. KOZARICH AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT JEFFREY R. PERRY AS A DIRECTOR | Management | For | For |
| 2 | RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: MANNKIND CORPORATION MEETING DATE: 05/22/2008 | ||||
| TICKER: MNKD SECURITY ID: 56400P201 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT ALFRED E. MANN AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT HAKAN S. EDSTROM AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT ABRAHAM E. COHEN AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT RONALD J. CONSIGLIO AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT MICHAEL A. FRIEDMAN, MD AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT HEATHER HAY MURREN AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT KENT KRESA AS A DIRECTOR | Management | For | For |
| 1. 8 | ELECT DAVID H. MACCALLUM AS A DIRECTOR | Management | For | For |
| 1. 9 | ELECT HENRY L. NORDHOFF AS A DIRECTOR | Management | For | For |
| 2 | INCREASE MAXIMUM NUMBER OF SHARES THAT MAY BE ISSUED UNDER MANNKIND S 2004 EQUITY INCENTIVE PLAN FROM 9 MILLION TO 14 MILLION | Management | For | Against |
| 3 | RATIFICATION OF DELOITTE & TOUCHE LLP AS INDEPENDENT AUDITORS | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: MARTEK BIOSCIENCES CORPORATION MEETING DATE: 03/13/2008 | ||||
| TICKER: MATK SECURITY ID: 572901106 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | TO ELECT HARRY J. D ANDREA AS DIRECTOR | Management | For | For |
| 2 | TO ELECT POLLY B. KAWALEK AS DIRECTOR | Management | For | Against |
| 3 | TO ELECT JEROME C. KELLER AS DIRECTOR | Management | For | For |
| 4 | TO ELECT DOUGLAS J. MACMASTER, JR. AS DIRECTOR | Management | For | For |
| 5 | TO ELECT ROBERT H. MAYER AS DIRECTOR | Management | For | For |
| 6 | TO ELECT EUGENE H. ROTBERG AS DIRECTOR | Management | For | For |
| 7 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR 2008 | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: MEDAREX, INC. MEETING DATE: 05/15/2008 | ||||
| TICKER: MEDX SECURITY ID: 583916101 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT P.M. DANZON, PH.D.+ AS A DIRECTOR | Management | For | Withhold |
| 1. 2 | ELECT ROBERT C. DINERSTEIN+ AS A DIRECTOR | Management | For | Withhold |
| 1. 3 | ELECT HOWARD H. PIEN+ AS A DIRECTOR | Management | For | Withhold |
| 1. 4 | ELECT MARC RUBIN, M.D.++ AS A DIRECTOR | Management | For | Withhold |
| 2 | THE AMENDMENT AND RESTATEMENT OF MEDAREX S 2005 EQUITY INCENTIVE PLAN. | Management | For | For |
| 3 | THE RATIFICATION OF THE APPOINTMENT BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS MEDAREX S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: MEDIVATION, INC. MEETING DATE: 06/05/2008 | ||||
| TICKER: MDVN SECURITY ID: 58501N101 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT DANIEL D. ADAMS AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT GREGORY H. BAILEY, M.D. AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT KIM D. BLICKENSTAFF AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT DAVID T. HUNG, M.D. AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT W. ANTHONY VERNON AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP, AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: MILLENNIUM PHARMACEUTICALS, INC. MEETING DATE: 05/22/2008 | ||||
| TICKER: MLNM SECURITY ID: 599902103 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT DEBORAH DUNSIRE AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT ROBERT F. FRIEL AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT A. GRANT HEIDRICH, III AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT CHARLES J. HOMCY AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT RAJU S. KUCHERLAPATI AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT JEFFREY M. LEIDEN AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT MARK J. LEVIN AS A DIRECTOR | Management | For | For |
| 1. 8 | ELECT NORMAN C. SELBY AS A DIRECTOR | Management | For | For |
| 1. 9 | ELECT KENNETH E. WEG AS A DIRECTOR | Management | For | For |
| 1. 10 | ELECT ANTHONY H. WILD AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: MYRIAD GENETICS, INC. MEETING DATE: 11/15/2007 | ||||
| TICKER: MYGN SECURITY ID: 62855J104 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT PETER D. MELDRUM AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT MARK H. SKOLNICK, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT LINDA S. WILSON, PH.D. AS A DIRECTOR | Management | For | For |
| 2 | PROPOSAL TO AMEND THE 2003 EMPLOYEE, DIRECTOR AND CONSULTANT STOCK OPTION PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AVAILABLE FOR ISSUANCE THEREUNDER BY 1,500,000 SHARES. | Management | For | Against |
| 3 | PROPOSAL TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING JUNE 30, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: OMRIX BIOPHARMACEUTICALS, INC. MEETING DATE: 05/15/2008 | ||||
| TICKER: OMRI SECURITY ID: 681989109 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT LARRY ELLBERGER AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT BERNARD HOROWITZ, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT PAMELA W. MCNAMARA AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT KEVIN RAKIN AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT PHILIPPE ROMAGNOLI AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT STEVEN ST. PETER, M.D. AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT ROBERT TAUB AS A DIRECTOR | Management | For | For |
| 2 | THE RATIFICATION OF THE SELECTION BY THE BOARD OF KOST FORER GABBAY & KASIERER, A MEMBER OF ERNST & YOUNG GLOBAL, AS OMRIX INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ONYX PHARMACEUTICALS, INC. MEETING DATE: 05/14/2008 | ||||
| TICKER: ONXX SECURITY ID: 683399109 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT MAGNUS LUNDBERG AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT N. ANTHONY COLES AS A DIRECTOR | Management | For | For |
| 2 | TO APPROVE AN AMENDMENT TO THE COMPANY S 2005 EQUITY INCENTIVE PLAN TO INCREASE THE AGGREGATE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THAT PLAN BY 3,100,000 SHARES. | Management | For | For |
| 3 | TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR OUR FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ORACLE HEALTHCARE ACQUISITION CORP. MEETING DATE: 03/05/2008 | ||||
| TICKER: OHAQU SECURITY ID: 68402M201 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | TO ADOPT THE AGREEMENT AND PLAN OF MERGER DATED AS OF DECEMBER 3, 2007, BY AND AMONG ORACLE, PTI ACQUISITION SUB, INC., A WHOLLY-OWNED SUBSIDIARY OF ORACLE, AND PRECISION THERAPEUTICS, INC., AND APPROVE THE TRANSACTIONS CONTEMPLATED THEREBY. | Management | For | For |
| 2 | IF YOU HAVE VOTED AGAINST PROPOSAL 1 AND ARE EXERCISING YOUR CONVERSION RIGHTS, YOU MUST CHECK THE AGAINST BOX AND FOLLOW THE INSTRUCTIONS DESCRIBED IN THE MATERIALS. | Management | Unknown | For |
| 3 | TO CHANGE THE NAME FROM ORACLE HEALTHCARE ACQUISITION CORP. TO PRECISION THERAPEUTICS CORP . | Management | For | For |
| 4 | TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK TO 100,000,000 AND PREFERRED STOCK TO 20,000,000 SHARES. | Management | For | For |
| 5 | TO REMOVE CERTAIN BUSINESS COMBINATION PROVISIONS AND CLARIFY THE DATES ON WHICH THE TERMS OF EACH CLASS OF DIRECTORS WILL EXPIRE. | Management | For | For |
| 6 | TO INCREASE THE VOTING THRESHOLDS REQUIRED TO REMOVE A DIRECTOR FOR CAUSE. | Management | For | For |
| 7 | TO INCREASE THE VOTING THRESHOLD TO ADOPT, AMEND OR REPEAL PROVISION OF ORACLE S BYLAWS. | Management | For | For |
| 8 | TO REMOVE PROVISIONS ALLOWING FOR STOCKHOLDER ACTION BY WRITTEN CONSENT. | Management | For | For |
| 9 | ADOPT SUPERMAJORITY REQUIREMENT TO AMEND CHARTER | Management | For | For |
| 10 | TO APPROVE THE 2008 EQUITY INCENTIVE PLAN. | Management | For | For |
| 11 | TO AUTHORIZE THE ADJOURNMENT OF THE SPECIAL MEETING TO A LATER DATE, IF NECESSARY. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: OREXIGEN THERAPEUTICS INC MEETING DATE: 06/10/2008 | ||||
| TICKER: OREX SECURITY ID: 686164104 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT ECKARD WEBER, M.D. AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT G.D. TOLLEFSON, MD, PHD AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: OSI PHARMACEUTICALS, INC. MEETING DATE: 06/11/2008 | ||||
| TICKER: OSIP SECURITY ID: 671040103 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT ROBERT A. INGRAM AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT COLIN GODDARD, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT SANTO J. COSTA AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT DARYL K. GRANNER, M.D. AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT JOSEPH KLEIN, III AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT KENNETH B. LEE, JR. AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT VIREN MEHTA AS A DIRECTOR | Management | For | For |
| 1. 8 | ELECT DAVID W. NIEMIEC AS A DIRECTOR | Management | For | For |
| 1. 9 | ELECT H.M. PINEDO, MD, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 10 | ELECT KATHARINE B. STEVENSON AS A DIRECTOR | Management | For | For |
| 1. 11 | ELECT JOHN P. WHITE AS A DIRECTOR | Management | For | For |
| 2 | PROPOSAL TO RATIFY THE APPOINTMENT OF KPMG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE CORPORATION FOR THE FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: PDL BIOPHARMA, INC. MEETING DATE: 05/28/2008 | ||||
| TICKER: PDLI SECURITY ID: 69329Y104 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | ELECTION OF DIRECTOR: L. PATRICK GAGE, PH.D. | Management | For | For |
| 2 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: PHARMION CORPORATION MEETING DATE: 03/06/2008 | ||||
| TICKER: PHRM SECURITY ID: 71715B409 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | TO APPROVE AND ADOPT THE AGREEMENT AND PLAN OF MERGER, DATED NOVEMBER 18, 2007, BY AND AMONG CELGENE CORPORATION, COBALT ACQUISITION LLC AND PHARMION CORPORATION, WHICH PROVIDES FOR THE MERGER OF PHARMION CORPORATION WITH COBALT ACQUISITION LLC, AND TO APPROVE THE MERGER AND RELATED TRANSACTIONS ON THE TERMS DESCRIBED IN THE AGREEMENT AND PLAN OF MERGER. | Management | For | For |
| 2 | TO APPROVE THE ADJOURNMENT OF THE SPECIAL MEETING OF STOCKHOLDERS IF THERE ARE NOT SUFFICIENT VOTES AT THE TIME OF THE SPECIAL MEETING TO APPROVE AND ADOPT THE AGREEMENT AND PLAN OF MERGER AND TO APPROVE THE MERGER, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: PONIARD PHARMACEUTICALS, INC. MEETING DATE: 06/24/2008 | ||||
| TICKER: PARD SECURITY ID: 732449301 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT GERALD MCMAHON AS A DIRECTOR | Management | For | Withhold |
| 1. 2 | ELECT ROBERT S. BASSO AS A DIRECTOR | Management | For | Withhold |
| 1. 3 | ELECT FREDERICK B. CRAVES AS A DIRECTOR | Management | For | Withhold |
| 1. 4 | ELECT E. ROLLAND DICKSON AS A DIRECTOR | Management | For | Withhold |
| 1. 5 | ELECT CARL S. GOLDFISCHER AS A DIRECTOR | Management | For | Withhold |
| 1. 6 | ELECT ROBERT M. LITTAUER AS A DIRECTOR | Management | For | Withhold |
| 1. 7 | ELECT RONALD A. MARTELL AS A DIRECTOR | Management | For | Withhold |
| 1. 8 | ELECT NICHOLAS J. SIMON III AS A DIRECTOR | Management | For | Withhold |
| 1. 9 | ELECT DAVID R. STEVENS AS A DIRECTOR | Management | For | Withhold |
| 2 | PROPOSAL TO RATIFY APPOINTMENT OF KPMG LLP AS THE COMPANY S INDEPENDENT REGISTERED ACCOUNTING FIRM FOR 2008 | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: QIAGEN N.V. MEETING DATE: 07/20/2007 | ||||
| TICKER: QGEN SECURITY ID: N72482107 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | PROPOSAL TO APPROVE THE ACQUISITION OF DIGENE CORPORATION. | Management | For | None |
| 2 | PROPOSAL TO APPROVE AN AMENDMENT OF THE ARTICLES OF ASSOCIATION OF THE COMPANY. | Management | For | None |
| 3 | TO AUTHORIZE THE BOARD FOR A PERIOD OF FIVE YEARS, TO ISSUE ORDINARY AND FINANCING PREFERENCE SHARES OR RIGHTS TO SUBSCRIBE IN THE CAPITAL OF THE COMPANY, ALL AS FOR FULLY DESCRIBED IN THE PROXY STATEMENT. | Management | For | None |
| 4 | TO AUTHORIZE THE BOARD FOR A PERIOD OF FIVE YEARS, TO RESTRICT OR EXCLUDE THE PRE-EMPTION RIGHTS ACCRUING TO THE COMPANY S SHAREHOLDERS FOR UP TO A MAXIMUM OF 50% OF THE NUMBER OF ORDINARY SHARES. | Management | For | None |
| 5 | TO AUTHORIZE THE BOARD FOR A PERIOD OF FIVE YEARS, TO ISSUE PREFERENCE SHARES OR RIGHTS TO SUBSCRIBE FOR PREFERENCE SHARES IN THE CAPITAL OF THE COMPANY, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATMENT. | Management | For | None |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: QUIDEL CORPORATION MEETING DATE: 05/13/2008 | ||||
| TICKER: QDEL SECURITY ID: 74838J101 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT THOMAS D. BROWN AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT K.F. BUECHLER, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT ROD F. DAMMEYER AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT CAREN L. MASON AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT M.L POLAN, MD, PHD, MPH AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT MARK A. PULIDO AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT JACK W. SCHULER AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR OUR FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: REGENERON PHARMACEUTICALS, INC. MEETING DATE: 06/13/2008 | ||||
| TICKER: REGN SECURITY ID: 75886F107 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT A.G. GILMAN, M.D. PH.D. AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT J.L. GOLDSTEIN, M.D. AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT P. ROY VAGELOS, M.D. AS A DIRECTOR | Management | For | For |
| 2 | PROPOSAL TO APPROVE THE AMENDMENT AND RESTATEMENT OF THE COMPANY S 2000 LONG-TERM INCENTIVE PLAN, AS AMENDED (THE 2000 PLAN ), WHICH INCREASES BY 10,000,000 THE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE 2000 PLAN, EXTENDS THE TERM OF THE 2000 PLAN UNTIL DECEMBER 31, 2013, ALL AS MORE FULLY DESCRIBED IN THE PROXY STATEMENT. | Management | For | Against |
| 3 | PROPOSAL TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: RIGEL PHARMACEUTICALS, INC. MEETING DATE: 05/29/2008 | ||||
| TICKER: RIGL SECURITY ID: 766559603 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT WALTER H. MOOS, PH.D. AS A DIRECTOR | Management | For | Withhold |
| 1. 2 | ELECT HOLLINGS C. RENTON AS A DIRECTOR | Management | For | Withhold |
| 1. 3 | ELECT S.A. SHERWIN, M.D. AS A DIRECTOR | Management | For | Withhold |
| 2 | TO APPROVE AMENDMENTS TO THE COMPANY S 2000 EQUITY INCENTIVE PLAN (THE 2000 PLAN ) TO (I) INCREASE THE NUMBER OF SHARES AUTHORIZED FOR ISSUANCE UNDER THE 2000 PLAN BY 3,350,000 SHARES OF COMMON STOCK AND (II) PROVIDE THAT THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE UNDER THE 2000 PLAN SHALL BE REDUCED BY ONE SHARE FOR EACH SHARE OF COMMON STOCK. | Management | For | Against |
| 3 | TO APPROVE AN AMENDMENT TO THE COMPANY S 2000 NON-EMPLOYEE DIRECTORS STOCK PLAN (THE DIRECTORS PLAN ) TO INCREASE THE NUMBER OF SHARES AUTHORIZED FOR ISSUANCE UNDER THE DIRECTORS PLAN BY 100,000 SHARES OF COMMON STOCK. | Management | For | Against |
| 4 | TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: SANGAMO BIOSCIENCES, INC. MEETING DATE: 06/04/2008 | ||||
| TICKER: SGMO SECURITY ID: 800677106 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT EDWARD O. LANPHIER, II AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT WILLIAM G. GERBER, M.D. AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT JOHN W. LARSON AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT MARGARET A. LIU, M.D. AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT STEVEN J. MENTO, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT THOMAS G. WIGGANS AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT MICHAEL C. WOOD AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDED DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: SAVIENT PHARMACEUTICALS, INC. MEETING DATE: 05/13/2008 | ||||
| TICKER: SVNT SECURITY ID: 80517Q100 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT CHRISTOPHER G. CLEMENT AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT HERBERT CONRAD AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT ALAN L. HELLER AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT STEPHEN O. JAEGER AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT JOSEPH KLEIN III AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT LEE S. SIMON, M.D. AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT VIRGIL THOMPSON AS A DIRECTOR | Management | For | For |
| 2 | RATIFICATION OF THE APPOINTMENT OF MCGLADREY & PULLEN, LLP AS INDEPENDENT AUDITORS FOR THE 2008 FISCAL YEAR. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: SEPRACOR INC. MEETING DATE: 05/20/2008 | ||||
| TICKER: SEPR SECURITY ID: 817315104 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT ADRIAN ADAMS AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT TIMOTHY J. BARBERICH AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT TIMOTHY J. RINK AS A DIRECTOR | Management | For | For |
| 2 | TO APPROVE AN AMENDMENT TO SEPRACOR S 2000 STOCK INCENTIVE PLAN, OR 2000 PLAN, INCREASING FROM 13,500,000 TO 15,000,000 THE NUMBER OF SHARES OF SEPRACOR COMMON STOCK RESERVED FOR ISSUANCE UNDER THE 2000 PLAN. | Management | For | For |
| 3 | TO APPROVE THE ADOPTION OF SEPRACOR S 2008 DIRECTOR STOCK INCENTIVE PLAN. | Management | For | For |
| 4 | TO APPROVE AN AMENDMENT TO SEPRACOR S 1998 EMPLOYEE STOCK PURCHASE PLAN, OR 1998 ESPP, INCREASING FROM 1,400,000 TO 1,900,000 THE NUMBER OF SHARES OF SEPRACOR COMMON STOCK RESERVED FOR ISSUANCE UNDER THE 1998 ESPP. | Management | For | For |
| 5 | TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS SEPRACOR S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE CURRENT FISCAL YEAR. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: THERATECHNOLOGIES INC. MEETING DATE: 03/26/2008 | ||||
| TICKER: THTCF SECURITY ID: 88338H100 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | THE ELECTION OF DIRECTORS | Management | For | For |
| 2 | THE APPOINTMENT OF AUDITORS. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: THERAVANCE, INC. MEETING DATE: 04/22/2008 | ||||
| TICKER: THRX SECURITY ID: 88338T104 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT P. ROY VAGELOS, M.D. AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT RICK E. WINNINGHAM AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT JEFFREY M. DRAZAN AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT ROBERT V. GUNDERSON, JR AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT ARNOLD J. LEVINE, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT B.G. MALKIEL, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT WILLIAM H. WALTRIP AS A DIRECTOR | Management | For | For |
| 1. 8 | ELECT G.M. WHITESIDES, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 9 | ELECT WILLIAM D. YOUNG AS A DIRECTOR | Management | For | For |
| 2 | APPROVE AN AMENDMENT TO THE THERAVANCE, INC. EMPLOYEE STOCK PURCHASE PLAN (THE ESPP ) INCREASING THE AGGREGATE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE ESPP BY 300,000 SHARES, AS DESCRIBED IN THE PROXY STATEMENT. | Management | For | For |
| 3 | RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: UNITED THERAPEUTICS CORPORATION MEETING DATE: 05/29/2008 | ||||
| TICKER: UTHR SECURITY ID: 91307C102 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT RAYMOND DWEK AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT ROGER JEFFS AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT CHRISTOPHER PATUSKY AS A DIRECTOR | Management | For | For |
| 2 | APPROVAL OF THE AMENDED AND RESTATED 2008 UNITED THERAPEUTICS CORPORATION EQUITY INCENTIVE PLAN | Management | For | Against |
| 3 | RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS UNITED THERAPEUTICS CORPORATION S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2008 | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: VANDA PHARMACEUTICALS, INC. MEETING DATE: 05/08/2008 | ||||
| TICKER: VNDA SECURITY ID: 921659108 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT MR. RICHARD W. DUGAN AS A DIRECTOR | Management | For | Withhold |
| 1. 2 | ELECT DR. BRIAN K. HALAK AS A DIRECTOR | Management | For | Withhold |
| 2 | TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: VERTEX PHARMACEUTICALS INCORPORATED MEETING DATE: 05/15/2008 | ||||
| TICKER: VRTX SECURITY ID: 92532F100 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT STUART J.M. COLLINSON AS A DIRECTOR | Management | For | Withhold |
| 1. 2 | ELECT EUGENE H. CORDES AS A DIRECTOR | Management | For | Withhold |
| 1. 3 | ELECT MATTHEW W. EMMENS AS A DIRECTOR | Management | For | Withhold |
| 2 | THE APPROVAL OF AN AMENDMENT TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 200,000,000 TO 300,000,000. | Management | For | For |
| 3 | THE APPROVAL OF AN AMENDMENT TO THE 2006 STOCK AND OPTION PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE PLAN BY 6,600,000 SHARES FROM 7,302,380 SHARES TO 13,902,380 SHARES. | Management | For | Against |
| 4 | THE APPROVAL OF AN AMENDMENT TO THE EMPLOYEE STOCK PURCHASE PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE PLAN BY 2,000,000 SHARES. | Management | For | For |
| 5 | THE RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: XENOPORT, INC. MEETING DATE: 05/08/2008 | ||||
| TICKER: XNPT SECURITY ID: 98411C100 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT R.W. BARRETT, PH.D. AS A DIRECTOR | Management | For | Withhold |
| 1. 2 | ELECT JERYL L. HILLEMAN AS A DIRECTOR | Management | For | Withhold |
| 1. 3 | ELECT WENDELL WIERENGA, PH.D. AS A DIRECTOR | Management | For | Withhold |
| 2 | TO APPROVE AN AMENDMENT AND RESTATEMENT OF THE COMPANY S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE TOTAL NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE FROM 60 MILLION TO 150 MILLION SHARES. | Management | For | Against |
| 3 | TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2008. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ZYMOGENETICS, INC. MEETING DATE: 06/18/2008 | ||||
| TICKER: ZGEN SECURITY ID: 98985T109 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT J.A. HEMBERGER, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT JONATHAN S. LEFF AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT LARS REBIEN SORENSEN AS A DIRECTOR | Management | For | Withhold |
| 2 | APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
POWER OF ATTORNEY
I, the undersigned Treasurer of the following investment companies:
Fidelity Advisor Series I Fidelity Advisor Series VII Fidelity Advisor Series VIII Fidelity Beacon Street Trust Fidelity Capital Trust Fidelity Central Investment Portfolios LLC Fidelity Commonwealth Trust Fidelity Concord Street Trust Fidelity Congress Street Fund Fidelity Contrafund Fidelity Covington Trust Fidelity Destiny Portfolios Fidelity Devonshire Trust Fidelity Exchange Fund Fidelity Financial Trust | Fidelity Hanover Street Trust Fidelity Hastings Street Trust Fidelity Investment Trust Fidelity Magellan Fund Fidelity Mt. Vernon Street Trust Fidelity Puritan Trust Fidelity Securities Fund Fidelity Select Portfolios Fidelity Summer Street Trust Fidelity Trend Fund Variable Insurance Products Fund Variable Insurance Products Fund II Variable Insurance Products Fund III Variable Insurance Products Fund IV |
in addition to any other investment company for which Fidelity Management & Research Company or an affiliate acts as investment adviser and for which the undersigned individual serves as Treasurer (collectively, the "Funds"), hereby constitute and appoint Claire Walpole my true and lawful attorney-in-fact, with full power of substitution, and with full power to sign for me and in my name in the appropriate capacity, all Reports of the Proxy Voting Records of the Funds on Form N-PX under the Investment Company Act of 1940, as amended (the "Act"), or any successor thereto, and any supplements or other instruments in connection therewith, and generally to do all such things in my name and behalf in connection therewith as said attorney-in-fact deems necessary or appropriate to cause such Form to be completed and filed in accordance with the Act and all related requirements of the Securities and Exchange Commission. I hereby ratify and confirm all that said attorney-in-fact or her substitute may do or cause to be done by virtue hereof. This power of attorney is effective for all documents filed on or after June 11, 2008.
WITNESS my hand on this 11th day of June 2008.
/s/ Kenneth B. Robins
Kenneth B. Robins
Treasurer